EPILLO, the Blockchain-based health & fitness company, has launched its smart wearable products with a Digital Health Ecosystem. The EPILLO Health Systems was founded in 2020 with an approach to enable consumers to manage their health services, medicines, physical activity, diet & lifestyle for the prevention and control of Chronic & Lifestyle-based diseases. The healthcare conglomerate takes the assistance of medical evidence, consumer behavior and medical technology in making disruptive healthcare products & solutions.
EPILLO group is leveraging the multifarious utilities that blockchain technology offers in primarily healthcare and fitness applications, in a bid to solve some of the major issues in healthcare through its disruptive products and services.
EPILLO Health Systems focuses on consumer health and fitness with products & solutions in four major segments of Health & Fitness industries:
Health-focused Smart wearables (IOTs)
Digital-Health & Digital Therapeutics (DTx)
Retail Health & Medicine
Health-food & Nutrition
By combining the real-world inputs of smart wearable devices with the robust and secure execution framework of blockchain, EPILLO.io has built the world's most secure smart wearable range - FitMint Wear. The Smart Device range is backed by cryptographic guarantees, as well as open new incentive mechanisms in athletics and health while improving data sharing, device security, and transparency. This first-of-its-kind blockchain-based smartwatch - Fitmint Wear Pro, aims to offer a unique approach to how they use and store users' fitness and health data with wearable devices and adds engaging NFT-Gamification to level up users' health & fitness journey.
The companion decentralized mobile application (DAPP) will offer features like Move to Earn, NFT marketplace, Health-Fitness product marketplace, hosting people's health data on-chain, decentralized finance (DeFi) and more. The DAPP will be available on Google Play and iOS store by the end of December 2022.
Smartwatch-connected Health Suite on the other hand will offer Food & Medicine management for people with Chronic Diseases. The aforementioned Drug-Food Interaction management technology assists in medicine and food management for people with chronic conditions to help curb Adverse Drug Events (ADEs), low drug-adherence rates and medication errors. This WIPO-Gazetted Technology developed by EPILLO Health Systems was appraised at a valuation of $150 million.
EPILLO Health Systems will begin pre-booking of their Blockchain-based IoT smartwatch- FitMint Wear in December 2022 for an early January 2023 dispatch.
Join the HealthXL Webinar on ‘The Potential of AI in Drug Discovery’ on 6th December. Click here to Request to Join.
Click here to read the original news article.